ALPN-101: Clinical Trials

3 trials of ALPN-101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow ALPN-101: new trials by email Literature Review of ALPN-101 trials Research Report on ALPN-101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus
ALPN-101, Placebo - Systemic Lupus Erythematosus
Phase 2CompletedAlpine Immune Sciences Inc, A Subsidiary of Vertex762021-06-222025-08-15
ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD
ALPN-101 - Graft Vs Host Disease
Phase 1TerminatedAlpine Immune Sciences, Inc.12020-05-112023-08-28
Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety
ALPN-101, Placebo - Healthy Volunteers
Phase 1CompletedAlpine Immune Sciences, Inc.962019-01-292019-12-05

Conditions studied

Autoimmune Diseases (1)  ·  Graft vs Host Disease (1)  ·  Immune System Diseases (1)  ·  Lupus Erythematosus, Systemic (1)

Sponsors

Alpine Immune Sciences, Inc. (2)  ·  Alpine Immune Sciences Inc, A Subsidiary of Vertex (1)

Countries

United States (2)  ·  Australia (1)  ·  France (1)  ·  Hungary (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Jan Hillson, MD (1)